A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.
Number of shares, 3 months chart
Year | Volume (Price x Shares) | Change |
---|---|---|
2023 | โฌ52.96 M | -33.99% |
2022 | โฌ80.23 M | 43.67% |
2021 | โฌ55.84 M | 83.78% |
2020 | โฌ30.38 M |
Company | FTD volume (3 months) | FTD volume (1 year) | Country |
---|---|---|---|
![]() ImmunoGen
IMGN | N/A | โฌ8.25 M | ๐บ๐ธ USA |
![]() Biogen BIIB | โฌ8.78 M | โฌ62.76 M | ๐บ๐ธ USA |
![]() Celldex Therapeutics CLDX | โฌ1.52 M | โฌ8.38 M | ๐บ๐ธ USA |
![]() Spectrum Pharmaceuticals
SPPI | N/A | โฌ0.06 M | ๐บ๐ธ USA |
![]() Pfizer PFE | โฌ26.37 M | โฌ0.27 B | ๐บ๐ธ USA |
![]() GlaxoSmithKline GSK | โฌ0.11 B | โฌ0.38 B | ๐ฌ๐ง UK |
![]() AbbVie ABBV | โฌ25.73 M | โฌ0.20 B | ๐บ๐ธ USA |
![]() Bristol-Myers Squibb BMY | โฌ11.54 M | โฌ0.26 B | ๐บ๐ธ USA |